Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


20.02.2017

3 Arch Virol
1 BMC Pediatr
1 BMJ
3 Clin Infect Dis
2 J Infect Dis
3 Lancet Glob Health
2 Lancet Respir Med
1 MMWR Morb Mortal Wkly Rep
2 Pediatr Infect Dis J
1 PLoS Comput Biol
7 PLoS One
1 Proc Natl Acad Sci U S A
22 Vaccine
1 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. KWAK BO, Lee HJ, Kang HM, Oh CE, et al
    Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children.
    Arch Virol. 2017 Feb 15. doi: 10.1007/s00705-017-3276.
    PubMed     Text format     Abstract available

  2. ZHANG M, Ge J, Wen Z, Chen W, et al
    Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus.
    Arch Virol. 2017;162:359-367.
    PubMed     Text format     Abstract available

  3. WU W, Liu S, Yu P, Tao X, et al
    Role of systemic injection of rabies immunoglobulin in rabies vaccination.
    Arch Virol. 2017 Feb 10. doi: 10.1007/s00705-017-3263.
    PubMed     Text format     Abstract available


    BMC Pediatr

  4. CHERUVU VK, Bhatta MP, Drinkard LN
    Factors associated with parental reasons for "no-intent" to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008-2012.
    BMC Pediatr. 2017;17:52.
    PubMed     Text format     Abstract available


    BMJ

  5. GULLAND A
    Sixty seconds on . . . swine flu vaccine.
    BMJ. 2017;356:j749.
    PubMed     Text format    


    Clin Infect Dis

  6. LEVI M, Ravaldi C, Pontello V, Bonaiuti R, et al
    Influenza vaccination and stillbirth prevention in high income countries: Is it really that effective?
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    

  7. OLARTE L, Barson WJ, Barson RM, Romero JR, et al
    Pneumococcal Pneumonia Requiring Hospitalization in U.S. Children in the 13-Valent Pneumococcal Conjugate Vaccine Era.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    

  8. SUTTER RW, Okayasu H, Kieny MP
    Next generation inactivated poliovirus vaccine: The future has arrived.
    Clin Infect Dis. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    


    J Infect Dis

  9. MANOR Y, Lewis M, Ram D, Daudi N, et al
    Evidence for Hepatitis A Virus Endemic Circulation in Israel Despite Universal Toddler Vaccination Since 1999 and Low Clinical Incidence in All Age Groups.
    J Infect Dis. 2016 Dec 24. doi: 10.1093.
    PubMed     Text format    

  10. JANES HE, Cohen KW, Frahm N, De Rosa SC, et al
    Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


    Lancet Glob Health

  11. DE SILVA TI, Kampmann B
    Value of immunogenicity studies of influenza vaccine in resource-limited settings.
    Lancet Glob Health. 2017;5:e274.
    PubMed     Text format    

  12. DOUGAN G
    Typhoid in Africa and vaccine deployment.
    Lancet Glob Health. 2017;5:e236-e237.
    PubMed     Text format    

  13. SNAPE MD
    Persistence of immune responses induced by Ebola virus vaccines.
    Lancet Glob Health. 2017;5:e238-e239.
    PubMed     Text format    


    Lancet Respir Med

  14. FIELDING JE
    Influenza vaccine effectiveness using the test-negative design: comparability and methodological challenges in meta-analyses.
    Lancet Respir Med. 2017 Feb 8. pii: S2213-2600(17)30044.
    PubMed     Text format    

  15. DARVISHIAN M, van den Heuvel ER, Bissielo A, Castilla J, et al
    Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
    Lancet Respir Med. 2017 Feb 8. pii: S2213-2600(17)30043.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  16. FLANNERY B, Chung JR, Thaker SN, Monto AS, et al
    Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.
    MMWR Morb Mortal Wkly Rep. 2017;66:167-171.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  17. LIVNI G, Wainstein A, Birk E, Chodick G, et al
    Influenza Vaccination Rate and Reasons for Non-Vaccination in Children with Cardiac Disease.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001579.
    PubMed     Text format     Abstract available

  18. CHRISTELLE TX, Min CS, Lee LY, Ong C, et al
    Serologic Responses After Hepatitis B Vaccination in Preterm Infants Born to Hepatitis B Surface Antigen Positive Mothers: Singapore Experience.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001578.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  19. BRADBURY NV, Probert WJ, Shea K, Runge MC, et al
    Quantifying the Value of Perfect Information in Emergency Vaccination Campaigns.
    PLoS Comput Biol. 2017;13:e1005318.
    PubMed     Text format     Abstract available


    PLoS One

  20. PICAZO J, Ruiz-Contreras J, Casado-Flores J, Negreira S, et al
    Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.
    PLoS One. 2017;12:e0172222.
    PubMed     Text format     Abstract available

  21. ROJO JU, Melkus MW, Kottapalli KR, Okiya OE, et al
    Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons.
    PLoS One. 2017;12:e0171677.
    PubMed     Text format     Abstract available

  22. MENG FY, Sun Y, Shen YG, Pan HF, et al
    Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China.
    PLoS One. 2017;12:e0172108.
    PubMed     Text format     Abstract available

  23. DE GROOT AS, Tounkara K, Rochas M, Beseme S, et al
    Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.
    PLoS One. 2017;12:e0171631.
    PubMed     Text format     Abstract available

  24. DOMINGUEZ A, Soldevila N, Toledo D, Torner N, et al
    Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.
    PLoS One. 2017;12:e0171943.
    PubMed     Text format     Abstract available

  25. HRADILOVA N, Sadilkova L, Palata O, Mysikova D, et al
    Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
    PLoS One. 2017;12:e0171539.
    PubMed     Text format     Abstract available

  26. GUTHRIE JL, Fisman D, Gardy JL
    Self-rated health and reasons for non-vaccination against seasonal influenza in Canadian adults with asthma.
    PLoS One. 2017;12:e0172117.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  27. KAZMIN D, Nakaya HI, Lee EK, Johnson MJ, et al
    Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.
    Proc Natl Acad Sci U S A. 2017 Feb 13. pii: 201621489.
    PubMed     Text format     Abstract available


    Vaccine

  28. XU H, Li X, Cui Z
    Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles. Ruwona TB, Xu H, Li X, Taylor AN, Shi Y, Cui Z. Vaccine 2016;34:3059-67.
    Vaccine. 2017;35:1102-1103.
    PubMed     Text format    

  29. MOLD M, Shardlow E, Exley C
    Toward understanding the mechanisms underlying the strong adjuvant activity of aluminium salt nanoparticles. Ruwona TB, Xu H, Li X, Taylor AN, Shi Y, Cui Z. Vaccine 2016;34:3059-67.
    Vaccine. 2017;35:1101.
    PubMed     Text format    

  30. POLLET J, Versteeg L, Rezende W, Strych U, et al
    A simple fluorescence-based assay for quantification of the Toll-Like Receptor agonist E6020 in vaccine formulations.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30157.
    PubMed     Text format     Abstract available

  31. MCHUGH L, Andrews RM, Lambert SB, Viney KA, et al
    Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30155.
    PubMed     Text format     Abstract available

  32. YANG FL, Lou TC, Kuo SC, Wu WL, et al
    A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30126.
    PubMed     Text format     Abstract available

  33. KHAN AI, Ali M, Chowdhury F, Saha A, et al
    Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.
    Vaccine. 2017 Feb 11. pii: S0264-410X(17)30160.
    PubMed     Text format     Abstract available

  34. TAHA MK, Hawkins JC, Liberator P, Deghmane AE, et al
    Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30146.
    PubMed     Text format     Abstract available

  35. ESQUERRE M, Momot M, Goubier A, Gonindard C, et al
    GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30154.
    PubMed     Text format     Abstract available

  36. MEIJER WJ, Wensing AM, Bos AA, Kuiphuis JC, et al
    Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30145.
    PubMed     Text format     Abstract available

  37. TRINH L, Macartney K, McIntyre P, Chiu C, et al
    Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic General Practice data.
    Vaccine. 2017 Feb 12. pii: S0264-410X(17)30143.
    PubMed     Text format     Abstract available

  38. CHAPPUIS F, Farinelli T, Deckx H, Sarnecki M, et al
    Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30080.
    PubMed     Text format     Abstract available

  39. FUCHS LI, Fort MC, Cano D, Bonetti CM, et al
    Clearance of Tritrichomonas foetus in experimentally infected heifers protected with vaccines based on killed-T. foetus with different adjuvants.
    Vaccine. 2017;35:1341-1346.
    PubMed     Text format     Abstract available

  40. LARROUY-MAUMUS G, Layre E, Clark S, Prandi J, et al
    Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30159.
    PubMed     Text format     Abstract available

  41. JARRAHIAN C, Rein-Weston A, Saxon G, Creelman B, et al
    Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV).
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30050.
    PubMed     Text format     Abstract available

  42. LENNY BJ, Sonnberg S, Danner AF, Friedman K, et al
    Evaluation of multivalent H2 influenza pandemic vaccines in mice.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30061.
    PubMed     Text format     Abstract available

  43. SCHAID DJ, Haralambieva IH, Larrabee BR, Ovsyannikova IG, et al
    Heritability of vaccine-induced measles neutralizing antibody titers.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30158.
    PubMed     Text format     Abstract available

  44. MADAN A, Ferguson M, Sheldon E, Segall N, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.
    Vaccine. 2017 Feb 7. pii: S0264-410X(17)30119.
    PubMed     Text format     Abstract available

  45. ZHENG X, Yang X, Li X, Qiu GH, et al
    Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
    Vaccine. 2017 Feb 7. pii: S0264-410X(17)30147.
    PubMed     Text format     Abstract available

  46. WORLD HEALTH ORGANIZATION
    Dengue vaccine: WHO position paper, July 2016 - recommendations.
    Vaccine. 2017;35:1200-1201.
    PubMed     Text format     Abstract available

  47. BALASUBRAMANIAN P, Kumar R, Williams C, Itri V, et al
    Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.
    Vaccine. 2017 Feb 6. pii: S0264-410X(17)30089.
    PubMed     Text format     Abstract available

  48. PEREZ AC, Murphy TF
    Do we need a vaccine against Moraxella catarrhalis in chronic lung disease? What are the options and opportunities?
    Vaccine. 2017 Feb 6. pii: S0264-410X(16)31300.
    PubMed     Text format     Abstract available

  49. NARWANEY KJ, Breslin K, Ross CA, Shoup JA, et al
    Vaccine adverse events in a safety net healthcare system and a managed care organization.
    Vaccine. 2017;35:1335-1340.
    PubMed     Text format     Abstract available


    Wkly Epidemiol Rec


  50. Tetanus vaccines: WHO position paper - February 2017.
    Wkly Epidemiol Rec. 2017;92:53-76.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: